Skip to main content

RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment.

Publication ,  Conference
Ratliff, BE; Bean, G; Marcom, PK; Scott, JV; Yee, L; Kimler, BF; Fabian, CJ; Zalles, CM; Shaw, H; Seewaldt, VL
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

100S / 100S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ratliff, B. E., Bean, G., Marcom, P. K., Scott, J. V., Yee, L., Kimler, B. F., … Seewaldt, V. L. (2004). RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 100S-100S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Ratliff, B. E., G. Bean, P. K. Marcom, J. V. Scott, L. Yee, B. F. Kimler, C. J. Fabian, C. M. Zalles, H. Shaw, and V. L. Seewaldt. “RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment.” In JOURNAL OF CLINICAL ONCOLOGY, 22:100S-100S. AMER SOC CLINICAL ONCOLOGY, 2004.
Ratliff BE, Bean G, Marcom PK, Scott JV, Yee L, Kimler BF, et al. RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 100S-100S.
Ratliff, B. E., et al. “RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment.JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 100S-100S.
Ratliff BE, Bean G, Marcom PK, Scott JV, Yee L, Kimler BF, Fabian CJ, Zalles CM, Shaw H, Seewaldt VL. RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 100S-100S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

July 15, 2004

Volume

22

Issue

14

Start / End Page

100S / 100S

Location

New Orleans, LA

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

40th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences